JPS61239890A - 安定化ペルオキシダ−ゼ溶液 - Google Patents
安定化ペルオキシダ−ゼ溶液Info
- Publication number
- JPS61239890A JPS61239890A JP7984985A JP7984985A JPS61239890A JP S61239890 A JPS61239890 A JP S61239890A JP 7984985 A JP7984985 A JP 7984985A JP 7984985 A JP7984985 A JP 7984985A JP S61239890 A JPS61239890 A JP S61239890A
- Authority
- JP
- Japan
- Prior art keywords
- peroxidase
- solution
- acid
- stabilized
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108040007629 peroxidase activity proteins Proteins 0.000 title claims abstract description 49
- 102000003992 Peroxidases Human genes 0.000 title claims 14
- 239000002253 acid Substances 0.000 claims abstract description 13
- 102000004506 Blood Proteins Human genes 0.000 claims abstract description 10
- 108010017384 Blood Proteins Proteins 0.000 claims abstract description 10
- 240000003291 Armoracia rusticana Species 0.000 claims abstract description 5
- 235000011330 Armoracia rusticana Nutrition 0.000 claims abstract description 5
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 claims abstract 3
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000000427 antigen Substances 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 150000001735 carboxylic acids Chemical class 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 1
- 102000013415 peroxidase activity proteins Human genes 0.000 abstract description 35
- 239000000243 solution Substances 0.000 abstract description 21
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 102000007562 Serum Albumin Human genes 0.000 abstract description 3
- 108010071390 Serum Albumin Proteins 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 235000019260 propionic acid Nutrition 0.000 abstract 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 1
- 238000010790 dilution Methods 0.000 description 17
- 239000012895 dilution Substances 0.000 description 17
- 230000000694 effects Effects 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 238000000034 method Methods 0.000 description 6
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 5
- 229940025294 hemin Drugs 0.000 description 5
- 229920006130 high-performance polyamide Polymers 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000000087 stabilizing effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000000984 immunochemical effect Effects 0.000 description 3
- 238000011532 immunohistochemical staining Methods 0.000 description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010005991 Pork Regular Insulin Proteins 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-N mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OCUIPDGJXYIRKY-UHFFFAOYSA-N C(CC(O)(C(=O)O)CC(=O)O)(=O)O.[P] Chemical compound C(CC(O)(C(=O)O)CC(=O)O)(=O)O.[P] OCUIPDGJXYIRKY-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- 101000993800 Sus scrofa Insulin Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000019846 buffering salt Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7984985A JPS61239890A (ja) | 1985-04-15 | 1985-04-15 | 安定化ペルオキシダ−ゼ溶液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7984985A JPS61239890A (ja) | 1985-04-15 | 1985-04-15 | 安定化ペルオキシダ−ゼ溶液 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61239890A true JPS61239890A (ja) | 1986-10-25 |
JPS6324677B2 JPS6324677B2 (enrdf_load_stackoverflow) | 1988-05-21 |
Family
ID=13701643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7984985A Granted JPS61239890A (ja) | 1985-04-15 | 1985-04-15 | 安定化ペルオキシダ−ゼ溶液 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61239890A (enrdf_load_stackoverflow) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516672A (en) * | 1988-04-26 | 1996-05-14 | Konica Corporation | Stabilized peroxidase compositions and antibody compositions |
-
1985
- 1985-04-15 JP JP7984985A patent/JPS61239890A/ja active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516672A (en) * | 1988-04-26 | 1996-05-14 | Konica Corporation | Stabilized peroxidase compositions and antibody compositions |
Also Published As
Publication number | Publication date |
---|---|
JPS6324677B2 (enrdf_load_stackoverflow) | 1988-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burch et al. | Improved method for measurement of delta-aminolevulinic acid dehydratase activity of human erythrocytes | |
Jung et al. | New colorimetric reaction for end-point, continuous-flow, and kinetic measurement of urea | |
JP3184894B2 (ja) | ハロペルオキシターゼ酸至適化学的発光分析系 | |
JPH0926423A (ja) | 不活性担体分子に対して複合体形成された被検体もしくはその部分配列を含む免疫アツセイで使用するための合成キヤリブレーター | |
JPS6122254A (ja) | バイオルミネツセンス連結結合定量法 | |
JPH0322946B2 (enrdf_load_stackoverflow) | ||
JPH0242982A (ja) | 安定なペルオキシダーゼ組成物及び安定な抗体組成物 | |
US6482648B2 (en) | Stable troponin preparation and the use thereof as a calibrator/control in immunoassays | |
JPH11316228A (ja) | 組換え組織因子に基づく、即時使用可能なプロトロンビン時間試薬 | |
EP0043285B1 (en) | Method for determination of valproic acid and reagents therein | |
JPS61239890A (ja) | 安定化ペルオキシダ−ゼ溶液 | |
JPH0677019B2 (ja) | 酵素標識抗体の安定化法 | |
US5342788A (en) | Method and standard solution for the determination of thyroxine (T4) or triiodothyronine (T3) | |
US5610076A (en) | Method for detecting hemoglobin advanced glycosylation endproducts | |
JPH03251764A (ja) | 緩衝化洗浄組成物および試験キットならびに使用方法 | |
JPWO2016021678A1 (ja) | 蛋白質安定化剤及び蛋白質安定化方法 | |
JP4178632B2 (ja) | 干渉作用を回避する方法及び試薬 | |
US5217890A (en) | Stabilized composition containing creatine kinase and protein having blocked sulfhydryl groups | |
JP2654932B2 (ja) | C−反応性蛋白質測定用試薬 | |
JP2000352565A (ja) | 尿検体中のアナライトの安定化方法およびこれに用いる保存剤 | |
CN102628871B (zh) | 甲状腺激素固定载体的液体试剂及其用途 | |
JPH07121235B2 (ja) | 過酸化物分解性物質測定用指示薬および試薬キット | |
EP0141581A2 (en) | Labelling system for specific binding assays | |
EP1596198B1 (en) | METHOD OF MEASURING OXIDIZED LDL-beta2-GPI-CRP COMPLEX | |
Lee et al. | A solid phase enzyme immunoassay for the quantitation of serum ferritin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |